Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2020 | Biomarkers in RCC

Martin Voss, MD, Memorial Sloan Kettering Cancer Center, New York, NY, discusses the main clinically useful biomarkers in renal cell carcinoma (RCC), how they can be used in decision-making, and whether why are ready from prime time. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.